Ketotifen Induces Primary Necrosis of Human Eosinophils
- 1 August 2005
- journal article
- research article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 21 (4) , 318-327
Abstract
Eosinophils are considered essential in the pathogenesis of allergy. Reduced eosinophil apoptosis is considered to be a key element in the formation of eosinophilia in allergic conditions. Antihistamines are widely used in the treatment of allergic disorders, but their effects on eosinophil apoptosis are poorly understood. The histamine H1-receptor antagonist, ketotifen, is available orally and as eye drops for the treatment of allergic symptoms. The aim of our study was to investigate the possible effect of ketotifen on constitutive eosinophil apoptosis and on interleukin (IL)-5-mediated eosinophil survival. Isolated peripheral blood eosinophils were cultured with or without the survival-prolonging cytokine IL-5 and ketotifen. Apoptosis was assessed by measuring the relative DNA content and by morphological analysis. Ketotifen was found to reverse eosinophil survival induced by interleukin-5. However, the flow cytometry histogram of DNA in propidium iodide–stained cells was not typical to apoptosis. Morphological analysis of the eosinophils by bright-field microscopy suggested that the effect of ketotifen was due to the induction of primary necrosis rather than apoptosis. Histological assessment of eosinophil ultrastructure by transmission electron microscopy confirmed signs of advanced necrosis. In summary, our results suggest that at clinically relevant drug concentrations, ketotifen induces primary necrosis in IL-5-treated human eosinophils.Keywords
This publication has 31 references indexed in Scilit:
- Efficacy and safety of single‐ and multiple‐dose ketotifen fumarate 0.025% ophthalmic solution in a pediatric populationPediatric Allergy and Immunology, 2004
- Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preferenceCurrent Medical Research and Opinion, 2004
- Effects of Ketotifen 0.025% and Lodoxamide 0.1% on Eosinophil Infiltration into the Guinea Pig Conjunctiva in a Model of Allergic ConjunctivitisJournal of Ocular Pharmacology and Therapeutics, 2003
- Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven diseaseThorax, 2001
- Tear levels of interferon‐γ, interleukin (IL) ‐2, IL‐4 and IL‐5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitisClinical & Experimental Allergy, 2000
- Apoptosis of eosinophils and lymphocytes in allergic inflammationJournal of Allergy and Clinical Immunology, 1999
- Rhinovirus infections: induction and modulation of airways inflammation in asthmaClinical & Experimental Allergy, 1999
- Delayed eosinophil programmed cell death in vitro: A common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis☆☆☆★★★Journal of Allergy and Clinical Immunology, 1997
- Inhibitory Effect of Cetirizine on Cytokine-Enhanced in Vitro Eosinophil SurvivalAnnals of Allergy, Asthma & Immunology, 1997
- The In Vitro and In Vivo Ocular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic AgentJournal of Ocular Pharmacology and Therapeutics, 1996